ARCC vs BBIO

Comparison between Ares Capital Corp (ARCC, Company) and BridgeBio Pharma Inc (BBIO, Company).

ARCC is from the Financial Services sector, while BBIO is from the Healthcare sector.

5-Year PerformanceARCC has outperformed BBIO, delivering a return of +9.8% compared to +4.3%

ARCC vs BBIO - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	ARCC(COMPANY)	BBIO(COMPANY)
Market Cap	$13B	$13B
Max Drawdown	84.31%	92.80%
Sharpe Ratio	-0.33	1.60
5Y Beta	0.75	1.08
Industry	Asset Management	Biotechnology
P/E Ratio	11.65	-18.19
Forward P/E	9.65	N/A
PEG Ratio	3.72	-3.24
Dividend Yield	10.10%	N/A
5Y Dividends CAGR	3.71%	N/A
5Y EPS CAGR	N/A	-3.14%
Debt to Equity	112.68%	-116.44%
Free Cash Flow Yield	-9.15%	-3.31%
P/S Ratio	4.37	22.33
P/B Ratio	0.97	123.68

Market Cap

Winner

ARCC

$13B

BBIO

$13B

Max Drawdown

Winner

ARCC

84.31%

BBIO

92.80%

Sharpe Ratio

ARCC

-0.33

Winner

BBIO

1.60

5Y Beta

Winner

ARCC

0.75

BBIO

1.08

Industry

ARCC

Asset Management

BBIO

Biotechnology

P/E Ratio

ARCC

11.65

Winner

BBIO

-18.19

Forward P/E

ARCC

9.65

BBIO

N/A

PEG Ratio

ARCC

3.72

Winner

BBIO

-3.24

Dividend Yield

ARCC

10.10%

BBIO

N/A

5Y Dividends CAGR

ARCC

3.71%

BBIO

N/A

5Y EPS CAGR

ARCC

N/A

BBIO

-3.14%

Debt to Equity

ARCC

112.68%

Winner

BBIO

-116.44%

Free Cash Flow Yield

ARCC

-9.15%

Winner

BBIO

-3.31%

P/S Ratio

Winner

ARCC

4.37

BBIO

22.33

P/B Ratio

Winner

ARCC

0.97

BBIO

123.68

ARCC vs BBIO - Historical Returns

Returns include dividend reinvestment.

Period	ARCC	BBIO
1 month	-0.37%	-14.89%
3 months	+0.20%	-12.12%
6 months	-1.70%	-0.39%
1 year	-4.17%	+96.00%
5 years(CAGR)	+9.80%	+4.27%
10 years(CAGR)	+12.29%	N/A
Max(CAGR)	+12.00%	+13.57%

Winner

ARCC

-0.37%

BBIO

-14.89%

Winner

ARCC

+0.20%

BBIO

-12.12%

ARCC

-1.70%

Winner

BBIO

-0.39%

ARCC

-4.17%

Winner

BBIO

+96.00%

5Y(CAGR)

Winner

ARCC

+9.80%

BBIO

+4.27%

10Y(CAGR)

ARCC

+12.29%

BBIO

N/A

Max(CAGR)

ARCC

+12.00%

Winner

BBIO

+13.57%

ARCC vs BBIO - Annual Returns (2004 - 2026)

Returns include dividend reinvestment.

Year	ARCC	BBIO
2026	-5.05%	-15.47%
2025	-0.34%	+171.24%
2024	+19.80%	-32.16%
2023	+19.29%	+463.04%
2022	-3.00%	-55.59%
2021	+39.31%	-73.79%
2020	+0.59%	+114.06%
2019	+32.01%	+27.22%
2018	+7.42%	N/A
2017	+4.97%	N/A
2016	+26.10%	N/A
2015	-0.64%	N/A
2014	-2.84%	N/A
2013	+9.64%	N/A
2012	+23.43%	N/A
2011	-0.05%	N/A
2010	+38.30%	N/A
2009	+130.17%	N/A
2008	-47.60%	N/A
2007	-16.31%	N/A
2006	+29.09%	N/A
2005	-7.15%	N/A
2004	+31.40%	N/A

ARCC vs BBIO Drawdown Comparison

The maximum drawdown for ARCC was -79.37%, occurring on Mar 5, 2009. Recovery took 715 trading sessions.

The maximum drawdown for BBIO was -92.80%, occurring on May 11, 2022. Recovery took 1211 trading sessions.

The current ARCC drawdown is -12.63%. The current BBIO drawdown is -17.24%.

Rank	ARCC	BBIO
#1	-79.37% Feb 22, 2007 - Dec 22, 2009	-92.80% Feb 8, 2021 - Dec 3, 2025
#2	-56.84% Feb 7, 2020 - Jan 20, 2021	-65.45% Dec 23, 2019 - Nov 24, 2020
#3	-24.60% Apr 29, 2011 - Feb 28, 2012	-44.53% Sep 3, 2019 - Nov 20, 2019
#4	-22.17% Apr 29, 2010 - Sep 29, 2010	-21.99% Dec 31, 2020 - Feb 8, 2021
#5	-21.89% Apr 6, 2015 - Jul 25, 2016	-20.25% Jan 22, 2026 - Feb 5, 2026
#6	-21.78% Apr 20, 2022 - Jul 26, 2023	-16.79% Nov 22, 2019 - Dec 9, 2019
#7	-20.10% Aug 4, 2005 - Sep 27, 2006	-14.67% Jul 22, 2019 - Aug 26, 2019
#8	-19.35% Dec 28, 2004 - Aug 3, 2005	-12.87% Jul 11, 2019 - Jul 22, 2019
#9	-19.33% Jul 17, 2025 - Mar 27, 2026	-6.70% Dec 12, 2019 - Dec 18, 2019
#10	-18.79% Feb 4, 2025 - Jul 10, 2025	-6.15% Jan 2, 2026 - Jan 13, 2026
#11	-17.20% Jan 19, 2010 - Mar 17, 2010	-5.62% Jul 5, 2019 - Jul 11, 2019
#12	-14.28% Nov 9, 2018 - Feb 20, 2019	-5.28% Aug 27, 2019 - Sep 3, 2019
#13	-13.99% Jun 30, 2014 - Feb 23, 2015	-4.46% Dec 1, 2020 - Dec 4, 2020
#14	-11.36% Apr 3, 2012 - Jul 13, 2012	-4.45% Dec 18, 2019 - Dec 20, 2019
#15	-10.76% Feb 8, 2022 - Apr 19, 2022	-4.13% Dec 4, 2025 - Dec 12, 2025